News

Regulatory affairsRegulatory Round-up - July 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
CGT Catapult helps Protostem-AI advance and conceptually validate its AI-driven stem cell platformCGT Catapult helps Protostem-AI advance and conceptually validate its AI-driven stem cell platformR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy productsR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy productsRegulatory Round-up - June 2026Regulatory Round-up - June 2026Regulatory Round-up - May 2026Regulatory Round-up - May 2026King's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumoursKing's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumoursCell and Gene Therapy Catapult invests in Lir Therapeutics to accelerate development of its AI-driven AAV design platformCell and Gene Therapy Catapult invests in Lir Therapeutics to accelerate development of its AI-driven AAV design platformR&D project spotlight: Advancing automated manufacturing in cell and gene therapiesR&D project spotlight: Advancing automated manufacturing in cell and gene therapiesRegulatory Round-up - April 2026Regulatory Round-up - April 2026Stratosvir secures support from Cell and Gene Therapy Catapult to advance innovative anticancer therapeuticsStratosvir secures support from Cell and Gene Therapy Catapult to advance innovative anticancer therapeuticsRegulatory Round-up - March 2026Regulatory Round-up - March 2026New survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductionsNew survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductionsRegulatory Round-up - February 2026Regulatory Round-up - February 2026